Form 4: Pacira BioSciences CFO Charles A. Reinhart III Reports Stock Transaction
SEC Form 4 Filing
Charles A. Reinhart III, CFO of Pacira BioSciences, reports a transaction involving the withholding of shares to cover tax obligations upon vesting of a restricted stock unit award.
Summary
- On June 3, 2024, Charles A. Reinhart III, the Chief Financial Officer of Pacira BioSciences, Inc., had shares withheld by the issuer to cover tax withholding obligations.
- A total of 2,979 shares of common stock were withheld at a price of $30.89 per share.
- Following the transaction, Reinhart directly owns 39,647 shares of Pacira BioSciences, Inc.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to tax obligations, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment with company performance.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider stock activity.
Key Dates
| Date | Description |
|---|---|
| 06/03/2024 | Date of stock transaction (shares withheld for tax obligations). |
| 06/05/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.